Physician profile
Erin Walker
NPI 1922322700
$786.94
in general payments reported to CMS, 2019-2025
20 companies · $174 in 2025
The $174 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $38.41 · 2023: $125 · 2024: $450 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $112.02 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $78.65 | 2024-2025 | |
| Pharmaessentia USA Corporation | $63.94 | 2024-2025 | Besremi |
| Novartis Pharmaceuticals Corporation | $56.84 | 2024 | |
| Myriad Genetic Laboratories, INC. | $53.13 | 2023 | Myrisk |
| Gilead Sciences, INC. | $49.99 | 2023 | Trodelvy |
| Glaxosmithkline, LLC. | $47.09 | 2024-2025 | Ojjaara |
| Genzyme Corporation | $45.87 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.82 | 2024 | Fruzaqla |
| Janssen Biotech, INC. | $36.08 | 2024 | Rybrevant |
| Eisai INC. | $35.36 | 2022-2024 | |
| Tempus Ai, INC | $25.64 | 2024 | |
| Adaptive Biotechnologies Corporation | $21.43 | 2023 | Clonoseq |
| Genentech USA, INC. | $20.84 | 2022 | |
| Stemline Therapeutics INC. | $20.39 | 2024 | Orserdu |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $19.49 | 2025 | Mektovi, Tukysa, Braftovi |
| Taiho Oncology, INC. | $17.64 | 2025 | |
| Pfizer INC. | $15.32 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $14.92 | 2025 | Opdivo |
| Pharmacosmos Therapeutics INC. | $13.48 | 2025 | Monoferric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.